Akoya Biosciences

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$18,814
$23,164
$18,350
$26,487
Gross Profit
11,724
13,386
8,379
14,746
EBITDA
-6,039
-8,570
-18,758
-6,425
EBIT
-7,864
-10,496
-20,809
-8,531
Net Income
-10,533
-13,149
-23,484
-10,802
Net Change In Cash
18,814
23,164
18,350
26,487
Free Cash Flow
-9,690
-11,211
-21,634
-6,145
Cash
12,557
8,923
13,039
83,125
Basic Shares
49,503
49,419
49,188
49,089

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$96,633
$74,859
$54,917
$42,443
Gross Profit
56,305
43,390
34,218
25,908
EBITDA
-45,632
-58,815
-35,168
-10,126
EBIT
-54,522
-65,964
-39,960
-13,941
Net Income
-63,323
-70,641
-42,935
-16,706
Net Change In Cash
96,633
74,859
54,917
42,443
Cost of Revenue
-38,849
95,873
Free Cash Flow
-54,552
-60,856
-41,162
-10,138
Cash
83,125
74,229
113,079
17,006
Basic Shares
44,434
37,746
37,424
37,110

Earnings Calls

Quarter EPS
2024-09-30
-$0.17
2024-06-30
-$0.27
2024-03-31
-$0.48
2023-12-31
-$0.22